Table 5.
Comparison of P-cadherin expression in different breast cancer subtypes
| IBC | Non-IBC | p-value | |
| n(%) | n(%) | ||
| Basal cases (ER-,ERBB2-) | 18/19(95%) | 35/51(69%) | 0.05 |
| ERBB2-overexpressing cases | 9/13(69%) | 32/47(68%) | NS |
| Luminal cases (ER+, PR+) | 14/17(82%) | 84/197(43%) | <0.01 |